Anthony James QP and Pharma Consultancy LTD

Anthony James QP and Pharma Consultancy LTD Accountants' Report For the year ended 28 February 2026
Report to the directors on the preparation of the unaudited statutory accounts of Anthony James QP and Pharma Consultancy LTD for the year ended 28 February 2026. In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Anthony James QP and Pharma Consultancy LTD for the year ended 28 February 2026 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com/. This report is made solely to the Board of Directors of Anthony James QP and Pharma Consultancy LTD, as a body, in accordance with the terms of our engagement letter dated 16 June 2022. Our work has been undertaken solely to prepare for your approval the accounts of Anthony James QP and Pharma Consultancy LTD and state those matters that we have agreed to state to the Board of Directors of Anthony James QP and Pharma Consultancy LTD, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Anthony James QP and Pharma Consultancy LTD and its Board of Directors as a body for our work or for this report. It is your duty to ensure that Anthony James QP and Pharma Consultancy LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Anthony James QP and Pharma Consultancy LTD. You consider that Anthony James QP and Pharma Consultancy LTD is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the accounts of Anthony James QP and Pharma Consultancy LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts 28 February 2026. .................................................... JLS & Co Accountants Ltd 112 Gilfach Street BARGOED CF81 8LQ 08 May 2026 1

Anthony James QP and Pharma Consultancy LTD
Accountants' Report
For the year ended 28 February 2026

Report to the directors on the preparation of the unaudited statutory accounts of Anthony James QP and Pharma Consultancy LTD for the year ended 28 February 2026.
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Anthony James QP and Pharma Consultancy LTD for the year ended 28 February 2026 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/.
This report is made solely to the Board of Directors of Anthony James QP and Pharma Consultancy LTD, as a body, in accordance with the terms of our engagement letter dated 16 June 2022. Our work has been undertaken solely to prepare for your approval the accounts of Anthony James QP and Pharma Consultancy LTD and state those matters that we have agreed to state to the Board of Directors of Anthony James QP and Pharma Consultancy LTD, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Anthony James QP and Pharma Consultancy LTD and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Anthony James QP and Pharma Consultancy LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Anthony James QP and Pharma Consultancy LTD. You consider that Anthony James QP and Pharma Consultancy LTD is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Anthony James QP and Pharma Consultancy LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
28 February 2026.

....................................................

JLS & Co Accountants Ltd
112 Gilfach Street
BARGOED
CF81 8LQ
08 May 2026

Anthony James QP and Pharma Consultancy LTD
Statement of Financial Position
As at 28 February 2026

	2026		2025
	£	£	£	£
Fixed assets		166		0
Current assets	70,303		60,191
Creditors: amount falling due within one year	(37,622)		(44,246)
Net current assets		32,681		15,945
Total assets less current liabilities		32,847		15,945
Net assets		32,847		15,945


Capital and reserves		32,847		15,945

NOTES TO THE ACCOUNTS

General Information

Anthony James QP and Pharma Consultancy LTD is a private company, limited by shares, registered in England and Wales, registration number 13200654, registration address 22 Tai'R Heol, Penpedairheol, HENGOED, CF82 8DL.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 4 (2025 : 3).

For the year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.

The financial statements were approved by the director on 08 May 2026 and were signed by:

--------------------------------
Anthony James
Director


Registered Number: 13200654
England and Wales
ANTHONY JAMES QP AND PHARMA CONSULTANCY LTD

Abridged Accounts

Period of accounts Start date: 01 March 2025 End date: 28 February 2026